Gilead Sciences (GILD) ROIC: History & Chart

Name: Gilead Sciences, Inc. (GILD) Return on Invested Capital (ROIC) — historical time series
Creator: TGMCharts

Compare

Gilead Sciences, Inc.(GILD)

Drug Manufacturers - General · Foster City, CA

$146.79-4.20 (-2.78%)

Delayed quote: Sep 8, 2026, 3:20 PM EDT

Compare

About Gilead Sciences, Inc.

Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.

Foster City, CA

17,000 employees

www.gilead.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: Daniel O'Day

View full financials

GILD Return on Invested Capital (ROIC) Metrics

RETURN ON INVESTED CAPITAL (ROIC)

-3.66%

RETURN ON INVESTED CAPITAL (ROIC) AVG TTM

13.65%

RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y

9.95%

RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y

11.22%

RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y

10.88%

RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y

13.49%

RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y

19.11%

CURRENT VS TTM AVG

-126.84%

CURRENT VS 3Y AVG

-136.82%

CURRENT VS 5Y AVG

-132.64%

CURRENT VS 10Y AVG

-133.68%

CURRENT VS 15Y AVG

-127.15%

CURRENT VS 20Y AVG

-119.17%

SECTOR MEDIAN · HEALTHCARE

8.75%

median of 90 covered companies

CURRENT VS SECTOR MEDIAN

-141.89%

vs the sector median at left

NAME	MARKET CAP	RETURN ON INVESTED CAPITAL (ROIC)	TTM	3Y	5Y
Gilead Sciences, Inc. (GILD)	$182.25B	-3.66%	13.65%	9.95%	11.22%
Abbott Laboratories (ABT)vs ›	$182.82B	6.07%	9.16%	9.70%	9.86%
Novo Nordisk A/S (NVO)vs ›	$200.83B	30.21%	34.36%	43.28%	43.42%
Pfizer Inc. (PFE)vs ›	$158.53B	9.33%	9.06%	10.61%	10.43%
Amgen Inc. (AMGN)vs ›	$213.09B	14.22%	11.04%	11.80%	12.80%
Danaher Corporation (DHR)vs ›	$144.95B	5.03%	5.92%	6.55%	6.70%
Thermo Fisher Scientific Inc. (TMO)vs ›	$224.62B	7.44%	7.81%	8.16%	9.11%
Vertex Pharmaceuticals Incorporated (VRTX)vs ›	$134.35B	17.33%	8.72%	13.98%	17.04%
Bristol-Myers Squibb Company (BMY)vs ›	$132.30B	15.47%	14.35%	12.24%	10.38%
Intuitive Surgical, Inc. (ISRG)vs ›	$123.94B	15.11%	12.85%	12.25%	11.92%

NAME

MARKET CAP

RETURN ON INVESTED CAPITAL (ROIC)

TTM

Gilead Sciences, Inc. (GILD)

$182.25B

-3.66%

13.65%

9.95%

11.22%

Abbott Laboratories (ABT)vs ›

$182.82B

6.07%

9.16%

9.70%

9.86%

Novo Nordisk A/S (NVO)vs ›

$200.83B

30.21%

34.36%

43.28%

43.42%

Pfizer Inc. (PFE)vs ›

$158.53B

9.33%

9.06%

10.61%

10.43%

Amgen Inc. (AMGN)vs ›

$213.09B

14.22%

11.04%

11.80%

12.80%

Danaher Corporation (DHR)vs ›

$144.95B

5.03%

5.92%

6.55%

6.70%

Thermo Fisher Scientific Inc. (TMO)vs ›

$224.62B

7.44%

7.81%

8.16%

9.11%

Vertex Pharmaceuticals Incorporated (VRTX)vs ›

$134.35B

17.33%

8.72%

13.98%

17.04%

Bristol-Myers Squibb Company (BMY)vs ›

$132.30B

15.47%

14.35%

12.24%

10.38%

Intuitive Surgical, Inc. (ISRG)vs ›

$123.94B

15.11%

12.85%

12.25%

11.92%

Return on Invested Capital (ROIC) Formula & Definition

ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)

Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.

Return on Invested Capital (ROIC) FAQ

What is the return on invested capital (ROIC) for Gilead Sciences, Inc. (GILD)?

The return on invested capital (ROIC) for GILD stock is -3.66%.

Is Gilead Sciences, Inc.'s return on invested capital (ROIC) high or low?

The return on invested capital (ROIC) of -3.66% is 133% below its 5-year average of 11.22%, near the low end of its 5-year range (-3.66%–20.31%).

What is the TTM average return on invested capital (ROIC) for Gilead Sciences, Inc. (GILD)?

The TTM average return on invested capital (ROIC) for GILD stock is 13.65%.

What is the 3Y average return on invested capital (ROIC) for Gilead Sciences, Inc. (GILD)?

The 3Y average return on invested capital (ROIC) for GILD stock is 9.95%.

What is the 5Y average return on invested capital (ROIC) for Gilead Sciences, Inc. (GILD)?

The 5Y average return on invested capital (ROIC) for GILD stock is 11.22%.

What is the 10Y average return on invested capital (ROIC) for Gilead Sciences, Inc. (GILD)?

The 10Y average return on invested capital (ROIC) for GILD stock is 10.88%.

What is the 15Y average return on invested capital (ROIC) for Gilead Sciences, Inc. (GILD)?

The 15Y average return on invested capital (ROIC) for GILD stock is 13.49%.

What is the 20Y average return on invested capital (ROIC) for Gilead Sciences, Inc. (GILD)?

The 20Y average return on invested capital (ROIC) for GILD stock is 19.11%.

DATE	RETURN ON INVESTED CAPITAL (ROIC)
2026-06-30	-3.66%
2026-03-31	20.31%
2025-12-31	19.15%
2025-09-30	17.55%
2025-06-30	14.91%
2025-03-31	15.32%
2024-12-31	2.36%
2024-09-30	1.18%
2024-06-30	3.85%
2024-03-31	1.85%
2023-12-31	11.82%
2023-09-30	12.74%
2023-06-30	11.97%
2023-03-31	12.56%
2022-12-31	10.62%
2022-09-30	8.04%
2022-06-30	9.49%
2022-03-31	9.96%
2021-12-31	12.84%
2021-09-30	15.47%
2021-06-30	12.46%
2021-03-31	4.18%
2020-12-31	3.75%
2020-09-30	3.34%
2020-06-30	-1.99%
2020-03-31	8.42%
2019-12-31	7.89%
2019-09-30	5.22%
2019-06-30	10.56%
2019-03-31	10.75%
2018-12-31	10.28%
2018-09-30	9.03%
2018-06-30	10.09%
2018-03-31	12.03%
2017-12-31	12.65%
2017-09-30	21.12%
2017-06-30	24.34%
2017-03-31	26.38%
2016-12-31	29.13%
2016-09-30	33.64%
2016-06-30	41.81%
2016-03-31	46.11%
2015-12-31	43.34%
2015-09-30	41.47%
2015-06-30	50.27%
2015-03-31	46.39%
2014-12-31	42.17%
2014-09-30	39.96%
2014-06-30	29.09%
2014-03-31	19.97%
2013-12-31	17.42%
2013-09-30	17.14%
2013-06-30	16.50%
2013-03-31	16.50%
2012-12-31	15.72%
2012-09-30	15.31%
2012-06-30	15.80%
2012-03-31	16.13%
2011-12-31	19.57%
2011-09-30	27.31%
2011-06-30	26.95%
2011-03-31	25.21%
2010-12-31	29.93%
2010-09-30	32.44%
2010-06-30	35.68%
2010-03-31	32.96%
2009-12-31	33.78%
2009-09-30	34.00%
2009-06-30	33.67%
2009-03-31	33.34%
2008-12-31	34.51%
2008-09-30	31.44%
2008-06-30	31.18%
2008-03-31	32.96%
2007-12-31	30.20%
2007-09-30	1.15%
2007-06-30	-9.64%
2007-03-31	-14.60%
2006-12-31	-22.71%
2006-09-30	14.50%
2006-06-30	19.57%
2006-03-31	23.73%
2005-12-31	23.16%
2005-09-30	23.45%
2005-06-30	23.24%
2005-03-31	23.08%
2004-12-31	22.73%
2004-09-30	27.12%
2004-06-30	28.76%
2004-03-31	27.96%
2003-12-31	-11.59%
2003-09-30	-20.66%
2003-06-30	-27.40%

DATE

RETURN ON INVESTED CAPITAL (ROIC)

2026-06-30

-3.66%

2026-03-31

20.31%

2025-12-31

19.15%

2025-09-30

17.55%

2025-06-30

14.91%

2025-03-31

15.32%

2024-12-31

2.36%

2024-09-30

1.18%

2024-06-30

3.85%

2024-03-31

1.85%

2023-12-31

11.82%

2023-09-30

12.74%

2023-06-30

11.97%

2023-03-31

12.56%

2022-12-31

10.62%

2022-09-30

8.04%

2022-06-30

9.49%

2022-03-31

9.96%

2021-12-31

12.84%

2021-09-30

15.47%

2021-06-30

12.46%

2021-03-31

4.18%

2020-12-31

3.75%

2020-09-30

3.34%

2020-06-30

-1.99%

2020-03-31

8.42%

2019-12-31

7.89%

2019-09-30

5.22%

2019-06-30

10.56%

2019-03-31

10.75%

2018-12-31

10.28%

2018-09-30

9.03%

2018-06-30

10.09%

2018-03-31

12.03%

2017-12-31

12.65%

2017-09-30

21.12%

2017-06-30

24.34%

2017-03-31

26.38%

2016-12-31

29.13%

2016-09-30

33.64%

2016-06-30

41.81%

2016-03-31

46.11%

2015-12-31

43.34%

2015-09-30

41.47%

2015-06-30

50.27%

2015-03-31

46.39%

2014-12-31

42.17%

2014-09-30

39.96%

2014-06-30

29.09%

2014-03-31

19.97%

2013-12-31

17.42%

2013-09-30

17.14%

2013-06-30

16.50%

2013-03-31

16.50%

2012-12-31

15.72%

2012-09-30

15.31%

2012-06-30

15.80%

2012-03-31

16.13%

2011-12-31

19.57%

2011-09-30

27.31%

2011-06-30

26.95%

2011-03-31

25.21%

2010-12-31

29.93%

2010-09-30

32.44%

2010-06-30

35.68%

2010-03-31

32.96%

2009-12-31

33.78%

2009-09-30

34.00%

2009-06-30

33.67%

2009-03-31

33.34%

2008-12-31

34.51%

2008-09-30

31.44%

2008-06-30

31.18%

2008-03-31

32.96%

2007-12-31

30.20%

2007-09-30

1.15%

2007-06-30

-9.64%

2007-03-31

-14.60%

2006-12-31

-22.71%

2006-09-30

14.50%

2006-06-30

19.57%

2006-03-31

23.73%

2005-12-31

23.16%

2005-09-30

23.45%

2005-06-30

23.24%

2005-03-31

23.08%

2004-12-31

22.73%

2004-09-30

27.12%

2004-06-30

28.76%

2004-03-31

27.96%

2003-12-31

-11.59%

2003-09-30

-20.66%

2003-06-30

-27.40%

Return on Invested Capital (ROIC): -3.66%

GILD Return on Invested Capital (ROIC)

GILD Average Return on Invested Capital (ROIC) Chart

GILD Current vs Average Return on Invested Capital (ROIC) Chart

GILD Return on Invested Capital (ROIC) Metrics

GILD Competitors' Return on Invested Capital (ROIC)

Capital Efficiency

Return on Invested Capital (ROIC) Formula & Definition

Return on Invested Capital (ROIC) FAQ

GILD Return on Invested Capital (ROIC) History

Related Metrics